1523618-34-9 Usage
Uses
Used in Pharmaceutical Industry:
[4-HydroxyMethyl-1-(toluene-4-sulfonyl)-piperidin-4-yl]-Methanol is used as a key intermediate in the synthesis of various pharmaceuticals for its chemical reactivity and functional properties. It contributes to the development of new drugs by facilitating the creation of complex molecular structures.
Used in Agrochemical Industry:
In the agrochemical sector, [4-HydroxyMethyl-1-(toluene-4-sulfonyl)-piperidin-4-yl]-Methanol is utilized as a building block in the production of agrochemicals, such as pesticides and herbicides. Its reactivity and properties allow for the creation of effective compounds designed to protect crops and enhance agricultural productivity.
Used as a Catalyst in Chemical Reactions:
[4-HydroxyMethyl-1-(toluene-4-sulfonyl)-piperidin-4-yl]-Methanol is employed as a catalyst in certain chemical reactions, enhancing the efficiency and selectivity of these processes. Its ability to act as a catalyst broadens its applications across various chemical industries, including the synthesis of specialty chemicals and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1523618-34-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,2,3,6,1 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1523618-34:
(9*1)+(8*5)+(7*2)+(6*3)+(5*6)+(4*1)+(3*8)+(2*3)+(1*4)=149
149 % 10 = 9
So 1523618-34-9 is a valid CAS Registry Number.
1523618-34-9Relevant academic research and scientific papers
Gurry, Michael,McArdle, Patrick,Aldabbagh, Fawaz
, p. 13864 - 13874 (2015)
A new synthesis of 2-oxa-7-azaspiro[3.5]nonane is described. Spirocyclic oxetanes, including 2-oxa-6-azaspiro[3.3]heptane were converted into o-cycloalkylaminoacetanilides for oxidative cyclizations using Oxone in formic acid. The expanded spirocyclic oxetane successfully gave the [1,2-a] ring-fused benzimidazole. X-ray crystal structure of the resultant new tetracyclic system, 1',2'-dihydro-4'H-spiro[oxetane-3,3'-pyrido[1,2-a]benzimidazole] and the azetidine ring-opened adduct, N-(2-acetamido-4-bromophenyl)-N-{[3-(chloromethyl) oxetan-3-yl]methyl}acetamide are disclosed.
